Efficacy and safety of dihydroartemisinin-piperaquine
Transactions of the Royal Society of Tropical Medicine and Hygiene 101(9): 858-866
Article 2007 English
Authors
HM
H. Myint
EA
Elizabeth A. Ashley
ND
Nicholas Day
Abstract
1 min read
Dihydroartemisinin-piperaquine, a fixed-dose combination antimalarial, is an inexpensive, safe and highly effective treatment for uncomplicated falciparum or vivax malaria. Efficacy assessed over 28-63 days has consistently exceeded 95% in the treatment of multidrug-resistant falciparum malaria. More than 2600 patients have been treated with this combination in prospective studies, mainly in Southeast Asia. Tolerability was uniformly good, and no serious adverse effects have been identified. The dosing regimen has been simplified from four doses to once daily over 3 days. More information on efficacy in Africa, and more pharmacokinetic and efficacy data in children are needed.
Frank Smithuis, Moe Kyaw Kyaw, Ohn Phe, Khin Zarli Aye, Linn Htet, M. Barends, Niklas Lindegårdh, Thida Singtoroj, Elizabeth A. Ashley, Saw Lwin, Kasia Stepniewska, Sir Nicholas White
Khin Maung Lwin, Aung Pyae Phyo, Joel Tärning, Warunee Hanpithakpong, Elizabeth A. Ashley, Sue J. Lee, Phaikyeong Cheah, Pratap Singhasivanon, Sir Nicholas White, Niklas Lindegårdh, François Nosten
Borimas Hanboonkunupakarn, Elizabeth A. Ashley, Podjanee Jittamala, Joel Tärning, Sasithon Pukrittayakamee, Warunee Hanpithakpong, Palang Chotsiri, Thanaporn Wattanakul, Salwaluk Panapipat, Sue J. Lee, Nicholas Day, Sir Nicholas White
Marcus J. Rijken, Rose McGready, Aung Pyae Phyo, Niklas Lindegårdh, Joel Tärning, Natthapon Laochan, Hla Hla Than, Oh Mu, Aye Kyi Win, Pratap Singhasivanon, Sir Nicholas White, François Nosten
Julien Zwang, Elizabeth A. Ashley, Corine Karema, Umberto D’Alessandro, Frank Smithuis, Grant Dorsey, Bart Janssens, Mayfong Mayxay, Paul N. Newton, Pratap Singhasivanon, Kasia Stepniewska, Sir Nicholas White, François Nosten
Discussion(0)
No comments yet. Be the first to comment.